Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6791218rdf:typepubmed:Citationlld:pubmed
pubmed-article:6791218lifeskim:mentionsumls-concept:C0058698lld:lifeskim
pubmed-article:6791218lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:6791218lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:6791218lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:6791218lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:6791218pubmed:issue2lld:pubmed
pubmed-article:6791218pubmed:dateCreated1981-10-29lld:pubmed
pubmed-article:6791218pubmed:abstractTextThe binding of 3H-cis flupenthixol (3H-FPT) to dopamine receptors in membrane preparations from control subjects and schizophrenics was studied. Using a fixed concentration of 3H-FPT, no differences were observed between controls and all schizophrenics, although 3H-FPT binding was increased in schizophrenics who apparently were drug-free at the time of death. Scatchard analysis of 3H-FPT binding revealed that in drug-treated schizophrenics both the number of binding sites (BM) and the dissociation constant (KD) were increased, whilst in drug-free schizophrenics only the BM was increased. Using domperidone to differentiate 3H-FPT binding to D1 and D2 dopamine sites, it was found that only D2 sites were increased in drug-free schizophrenics. The results are discussed with reference to previous studies on dopamine receptors in schizophrenia, and the effects of neuroleptic treatment. It is suggested that a selective increase in D2 receptors may be associated with the disease process in schizophrenia.lld:pubmed
pubmed-article:6791218pubmed:languageenglld:pubmed
pubmed-article:6791218pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6791218pubmed:citationSubsetIMlld:pubmed
pubmed-article:6791218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6791218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6791218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6791218pubmed:statusMEDLINElld:pubmed
pubmed-article:6791218pubmed:issn0033-3158lld:pubmed
pubmed-article:6791218pubmed:authorpubmed-author:CrowT JTJlld:pubmed
pubmed-article:6791218pubmed:authorpubmed-author:CrossA JAJlld:pubmed
pubmed-article:6791218pubmed:authorpubmed-author:OwenFFlld:pubmed
pubmed-article:6791218pubmed:issnTypePrintlld:pubmed
pubmed-article:6791218pubmed:volume74lld:pubmed
pubmed-article:6791218pubmed:ownerNLMlld:pubmed
pubmed-article:6791218pubmed:authorsCompleteYlld:pubmed
pubmed-article:6791218pubmed:pagination122-4lld:pubmed
pubmed-article:6791218pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:meshHeadingpubmed-meshheading:6791218-...lld:pubmed
pubmed-article:6791218pubmed:year1981lld:pubmed
pubmed-article:6791218pubmed:articleTitle3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.lld:pubmed
pubmed-article:6791218pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6791218pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6791218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6791218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6791218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6791218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6791218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6791218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6791218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6791218lld:pubmed